Includes drugs launched in: Canada, Belgium, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, the
United Kingdom, and the United States.
Citation formats
Oncology or orphan drug share in approved new active substances 2015-2023
This statistic depicts the percentage of orphan and oncology drugs released in Canada and select other developed countries that were new active substances (NAS) from 2015 to 2023. According to the data, in 2023, 63 percent of approved new active substances received an orphan drug designation.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PMPRB. (June 16, 2025). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2023 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2023." Chart. June 16, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. (2025). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2023. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of Orphan or Oncology Drugs among Approved New Active Substances (Nas) in Select Developed Countries from 2015 to 2023." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 16 Jun 2025, /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB, Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2023 ÌÇÐÄÆƽâ°æ, /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/ (last visited July 29, 2026)
Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2023 [Graph], PMPRB, June 16, 2025. [Online]. Available: /statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
